These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31743881)

  • 1. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma.
    Tang W; Liu W; Li HM; Wang QF; Fu CX; Wang XH; Zhou LP; Peng WJ
    Eur J Radiol; 2019 Dec; 121():108734. PubMed ID: 31743881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
    Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
    Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
    Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.
    Giesel FL; Bischoff H; von Tengg-Kobligk H; Weber MA; Zechmann CM; Kauczor HU; Knopp MV
    Chest; 2006 Jun; 129(6):1570-6. PubMed ID: 16778277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.
    Huang YS; Chen JL; Chen JY; Lee YF; Huang JY; Kuo SH; Yen RF; Chang YC
    Strahlenther Onkol; 2019 Aug; 195(8):707-718. PubMed ID: 30610356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Advanced Cervical Carcinoma: The Advantage of Perfusion Parameters From the Peripheral Region in Predicting the Early Response to Radiotherapy.
    Zhang Z; Wang Z; Zhao R
    Int J Gynecol Cancer; 2018 Sep; 28(7):1342-1349. PubMed ID: 29994909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
    Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
    J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
    Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
    Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
    Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
    Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
    Cao J; Pickup S; Rosen M; Zhou R
    Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer.
    Chen Y; Ding L; Zhang ZW; Wu XH; Que YT; Ma YR; Liu YY; Wen ZQ; Yang XY; Lu BL; Bao Y; Niu SQ; Yu SP
    Eur Radiol; 2024 Mar; 34(3):1471-1480. PubMed ID: 37665390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.